On June 11, 2019 Tarveda Therapeutics, Inc., a clinical stage biopharmaceutical company discovering and developing a new class of potent and selective precision oncology medicines for the treatment of patients with a wide range of solid tumor malignancies, reported that Drew Fromkin, President and Chief Executive Officer, will present at the Raymond James Life Sciences and MedTech Conference occurring June 18-19, 2019 in New York City (Press release, Tarveda Therapeutics, JUN 11, 2019, View Source [SID1234537001]). Tarveda presentation details:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Date: Tuesday, June 18, 2019
Time: 8:00am Eastern Time
Location: Lotte New York Palace, New York, NY